Brief: Glycomimetics Reports Highlights And Financial Results For Fourth Quarter And Full Year 2021
03/03/2022 13:04
March 3 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS REPORTS HIGHLIGHTS AND FINANCIAL RESULTS FOR
FOURTH QUARTER AND FULL YEAR 2021
* GLYCOMIMETICS INC - QTRLY NET LOSS PER COMMON SHARE -
BASIC AND
DILUTED $0.33
Source text for Eikon: ID:nBw86HnXCa
Further company coverage: GLYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering